Phase 3 data from the TRIUMPH-4 study, released in December of last year, showed 28.7% average body weight loss at the 12 mg dose over 68 weeks
And there is great variability in how much medical advice and support such online businesses provide, said Sarah Le Brocq of All About Obesity, a patient support group
Side effects and safety considerations Intranasal retatrutide presents a different side effect profile than injectable administration
A well-cared-for asparagus planting will generally produce for about 15 years without being replanted
Shed tirzepatide versus semaglutide programs Shed offers both tirzepatide and semaglutide, and the choice between them matters
In trials, retatrutide produced higher weight loss than Wegovy at the highest dose of each: 28.7% at 68 weeks on retatrutide 12 mg, versus 20.7% at 72 weeks on the newer Wegovy 7.2 mg dose, and 14.9% at 68 weeks on the older Wegovy 2.4 mg dose